Full-Time

Manager – IT Infrastructure Operations

August Bioservices

August Bioservices

51-200 employees

US-based CDMO for end-to-end drug development

No salary listed

Nashville, TN, USA

In Person

Category
DevOps & Infrastructure (2)
,
Required Skills
Microsoft Azure
Computer Networking
Vulnerability Analysis
AWS
Hyper-V
VMWare
Nutanix
Linux/Unix
Requirements
  • Bachelor’s Degree in Information Management/Information Technology, Computer Science, Engineering or equivalent field. Master’s Degree or equivalent work experience is a plus.
  • 5-8 Years of increasingly responsible experience in IT Infrastructure Management and operation in manufacturing and regulated industrial environments.
  • Experience managing OT infrastructure in Pharmaceutical, biotech, life sciences or CDMO/CMO manufacturing environment is a plus
  • Network Architecture & Segmentation: VLANs, Subnetting, Routing, NAT, Firewalls, Industrial DMZs, Micro-segmentation and secure remote access.
  • Manufacturing OT Infrastructure: Plant-floor networking, Vendor/OEM connectivity, Industrial equipment integration.
  • Systems & Platforms: Windows, Linux OS, Virtualization and Hyperconverged Platforms (Nutanix, Hyper V, VMWare)
  • Cloud Services: Azure and/or AWS, including hybrid IT/OT architectures.
  • Enterprise Technologies: Cisco, Meraki, Enterprise Storage, Backup, Disaster Recovery solutions.
  • Security Operations: Vulnerability Management, IAM, Incident Response, Infrastructure Security Controls.
  • Familiarity with OT cybersecurity Frameworks.
Responsibilities
  • Plan, design, deploy, and operate on-premises, cloud, and manufacturing OT infrastructure, including enterprise networks, plant-floor networks, servers, virtualization, storage, endpoints, and industrial connectivity.
  • Own infrastructure operations across IT and OT environments, including servers, storage, virtualization, enterprise and manufacturing networks (LAN, WAN, VPN), firewalls, industrial demilitarized zones (IDMZ), backup, disaster recovery, and system monitoring.
  • Ensure reliable and secure connectivity for manufacturing execution systems (MES), historians, SCADA, PLC-connected systems, laboratory systems, and validated production platforms.
  • Lead business continuity and disaster recovery (BC/DR) planning and testing for both enterprise and manufacturing-critical systems, minimizing downtime and production risk.
  • Develop scalable infrastructure roadmaps that support manufacturing expansion, new production lines, onboarding equipment, and technology modernization
  • Architect, implement, and maintain LAN/WAN segmentation strategies, including VLANs, subnetting, firewalls, NAT, and routing controls to reduce blast radius and enforce least-privilege access.
  • Lead the adoption of Zero Trust Architecture (ZTA) principles across IT and OT environments, including identity-based access, device trust, network micro-segmentation, and continuous monitoring.
  • Implement secure remote access models for internal users, vendors, and OEMs supporting manufacturing systems, ensuring controlled, auditable, and time-bound access.
  • Partner with Security, Manufacturing, and Automation teams to align segmentation and ZTA controls with operational uptime, validation, and safety requirements
  • Design and enforce IT/OT security architectures that protect manufacturing operations while supporting validated and regulated production environments.
  • Drive vulnerability and patch management strategies tailored to OT systems, balancing cybersecurity risk with manufacturing availability and change control requirements.
  • Elevate cybersecurity posture across IT and OT by leading infrastructure hardening, threat detection, monitoring, and remediation initiatives.
  • Lead IT and OT security incident response, including containment, investigation, remediation, root-cause analysis, and executive and regulatory reporting.
  • Ensure IT and OT infrastructure operations comply with GxP, FDA/EMA, SOX, GDPR, HIPAA, Privacy, and internal Quality Management System (QMS) requirements.
  • Support CSV/CSA and validation activities by providing compliant infrastructure designs, access controls, change management, and operational evidence.
  • Develop and maintain IT and OT infrastructure, cybersecurity, network segmentation, and data protection policies, standards, and SOPs.
  • Support audits, inspections, and assessments by providing documentation, diagrams, risk assessments, and remediation plans.
  • Govern managed service providers (MSPs), network vendors, OT integrators, automation partners, and cloud providers, ensuring alignment with security, compliance, and operational expectations.
  • Collaborate closely with Manufacturing, Automation, Engineering, Quality, and Supply Chain teams to ensure infrastructure and security controls supporting production schedules and equipment lifecycles.
Desired Qualifications
  • Master’s Degree or equivalent work experience is a plus.
  • Experience managing OT infrastructure in Pharmaceutical, biotech, life sciences or CDMO/CMO manufacturing environment is a plus.
  • Familiarity with OT cybersecurity Frameworks.

August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.

Company Size

51-200

Company Stage

Series B

Total Funding

$88.6M

Headquarters

Nashville, Tennessee

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Severe scarcity in sterile injectable manufacturing capacity drives customer demand for expansion.
  • 77% revenue growth from 2023 to 2024 demonstrates strong market traction and scaling.
  • Fully automated downstream inspection and labeling processes increase throughput and operational efficiency.

What critics are saying

  • Larger CDMOs like Catalent and Thermo Fisher expand vial capacity, undercutting August's pricing.
  • 30-month equipment procurement timelines risk client attrition to faster-scaling competitors.
  • FDA cGMP non-compliance in new filling suite could halt commercial production immediately.

What makes August Bioservices unique

  • Focused sterile injectable CDMO with end-to-end services from development through commercialization.
  • CEO Jenn Adams recognized as Healthcare Technology CEO of the Year in March 2026.
  • Specialized expertise in poorly soluble, highly viscous compounds and uncommon container sizes.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at August Bioservices who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

1%

2 year growth

0%
The Healthcare Technology Report
Mar 18th, 2026
Jenn Adams named Healthcare Technology CEO of the Year.

Jenn Adams named Healthcare Technology CEO of the Year. Published. March 18, 2026 At this year's NYC Awards Night, The Healthcare Technology Repo had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology. Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year. Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization. Accepting the award, Jenn shared: "When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment - all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It's indistinguishable to them who is on their team and who is on our team because we're working shoulder to shoulder to make sure the drug is advanced. And then we're bridging the innovation and bringing it to patients who need that innovation in the form of therapies." Please join The Healthcare Technology Repo in congratulating Jenn Adams on this well-deserved recognition. Picture: Jenn Adams speaks at NYC Awards Night

Teknovation.biz
Dec 13th, 2024
Tennessee Emerges As A Leading State For Bioscience R&D

A new report from the Biotechnology Innovation Organization (BIO) and TEConomy Partners LLC finds Tennessee has emerged as a leading state for bioscience research and development, with bioscience RD accounting... The post Tennessee emerges as a leading state for bioscience RD appeared first on Teknovation.biz.

Teknovation.biz
Jun 30th, 2024
News & Notes | Ut Research Foundation Welcomes Four Interns

Like this story? Please share!News & Notes | UT Research Foundation welcomes four interns ETSU's Innovation Lab Director Dr. Audrey Depelteau served as a judge at last week's 2024 SelectUSA Investment Summit.From Knoxville:To promote the commercialization of University of Tennessee (UT) innovations and to help train the next generation of commercialization professionals, the UT Research Foundation (UTRF) recently welcomed three new interns and one returning intern across its Knoxville and Memphis offices.In Knoxville, Andrea Gutierrez-Cortez and Lauren Williams , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. Jacob Hale is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK.and , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK

Teknovation.biz
Oct 22nd, 2023
News & Notes | Expansion Bucks For August Bioservices

Like this story? Please share!. .

Teknovation.biz
Jan 23rd, 2023
Launch Tennessee Provides Ssbci Update, Q4 Tn Deal Flow

Like this story? Please share!. .